ACM
Ativo Capital Management Portfolio holdings
AUM
$112M
This Quarter Return
-0.44%
1 Year Return
+19.84%
3 Year Return
+54.84%
5 Year Return
+112.75%
10 Year Return
+351.76%
AUM
$254M
AUM Growth
+$254M
(+9.8%)
Cap. Flow
+$29.2M
Cap. Flow
% of AUM
11.49%
Top 10 Holdings %
Top 10 Hldgs %
26.73%
Holding
209
New
47
Increased
64
Reduced
49
Closed
24
Top Buys
| 1 |
Sensata Technologies
ST
|
$7.11M |
| 2 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$4.78M |
| 3 |
Brookfield
BN
|
$3.84M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$3.41M |
| 5 |
Gilead Sciences
GILD
|
$3.05M |
Top Sells
| 1 |
NTT
Nippon Telegraph & Telephone
NTT
|
$3.24M |
| 2 |
RTN
Raytheon Company
RTN
|
$3.23M |
| 3 |
BP
BP
|
$2.51M |
| 4 |
Sanofi
SNY
|
$1.91M |
| 5 |
ENIA
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
|
$1.81M |
Sector Composition
| 1 | Technology | 23.84% |
| 2 | Healthcare | 21.43% |
| 3 | Industrials | 14.64% |
| 4 | Financials | 11.29% |
| 5 | Energy | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $11.2M | 4.41% | 208,284 +63,411 | +44% | +$3.41M |
|
|
TARO
2
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $7.56M | 2.98% | 49,142 +31,084 | +172% | +$4.78M |
|
|
CBI
3
DELISTED
Chicago Bridge & Iron Nv
CBI
| $7.48M | 2.95% | 129,231 +14,184 | +12% | +$821K |
|
|
4
Sensata Technologies
ST
$4.74B
| $7.11M | 2.8% | +159,575 | New | +$7.11M |
|
5
TE Connectivity
TEL
$61B
| $6.78M | 2.67% | 122,692 -25 | -0% | -$1.38K |
|
6
SAP
SAP
$317B
| $6.55M | 2.58% | 90,736 +3,299 | +4% | +$238K |
|
7
Pentair
PNR
$17.6B
| $5.99M | 2.36% | 91,462 +32 | +0% | +$2.1K |
|
8
Accenture
ACN
$162B
| $5.51M | 2.17% | 67,735 +3,770 | +6% | +$307K |
|
|
9
Brookfield
BN
$98.3B
| $4.87M | 1.92% | 108,282 +85,318 | +372% | +$3.84M |
|
10
CGI
GIB
$21.7B
| $4.79M | 1.89% | 141,843 -9,423 | -6% | -$318K |
|
11
Chubb
CB
$110B
| $3.76M | 1.48% | 35,849 -2 | -0% | -$210 |
|
12
Johnson & Johnson
JNJ
$427B
| $3.73M | 1.47% | 35,033 +2,410 | +7% | +$257K |
|
13
Microsoft
MSFT
$3.77T
| $3.56M | 1.4% | 76,700 -7,982 | -9% | -$370K |
|
14
Fiserv
FI
$75.1B
| $3.53M | 1.39% | 54,636 -3,304 | -6% | -$214K |
|
15
Dr. Reddy's Laboratories
RDY
$11.8B
| $3.51M | 1.38% | 66,694 +22,942 | +52% | +$1.21M |
|
16
General Dynamics
GD
$87.3B
| $3.5M | 1.38% | 27,550 -2,726 | -9% | -$346K |
|
17
Omnicom Group
OMC
$15.2B
| $3.49M | 1.38% | 50,727 +1,264 | +3% | +$87K |
|
18
Walt Disney
DIS
$213B
| $3.44M | 1.35% | 38,589 -589 | -2% | -$52.4K |
|
19
Exxon Mobil
XOM
$487B
| $3.4M | 1.34% | 36,146 +1,047 | +3% | +$98.5K |
|
20
Qualcomm
QCOM
$173B
| $3.38M | 1.33% | 45,227 -1,179 | -3% | -$88.2K |
|
21
Danaher
DHR
$147B
| $3.31M | 1.3% | 43,503 +1,009 | +2% | +$76.7K |
|
|
DTV
22
DELISTED
DIRECTV COM STK (DE)
DTV
| $3.25M | 1.28% | 37,544 +89 | +0.2% | +$7.7K |
|
23
UnitedHealth
UNH
$281B
| $3.21M | 1.27% | 37,235 -6,464 | -15% | -$557K |
|
24
Medtronic
MDT
$119B
| $3.17M | 1.25% | 51,087 -693 | -1% | -$42.9K |
|
|
25
Gilead Sciences
GILD
$140B
| $3.05M | 1.2% | +28,687 | New | +$3.05M |
|